Small amounts of a common antibiotic and anti-inflammatory drug can curb symptoms where a misplaced immune reaction (e.g., ...

For adolescents with severe alopecia areata (AA), baricitinib is efficacious for hair regrowth, according to a study ...

CKD and ESRD can have unpleasant cutaneous manifestations, including alopecia, but there are several helpful approaches to mitigating hair loss.

A YOUNG woman who developed stress-related alopecia has revealed how she went from being almost bald to having a bob in less ...

A research group, led by Dr. Pavel Majer from IOCB Prague, in collaboration with the laboratories of Barbara Slusher and ...

Adolescents with alopecia areata achieve hair regrowth with 80% or more of scalp coverage while taking the Janus kinase inhibitor baricitinib, a phase 3 study finds.

Masumi Tsunoda, a 45-year-old woman in Maebashi, Gunma Prefecture, who is an alopecia areata patient, was asked to design a headscarf for Licca-chan. Tsunoda contracted the disease 10 years ago.

HealthDay News — For adults with severe alopecia areata (AA), ivarmacitinib, a selective Janus kinase 1 (JAK1) inhibitor, at doses of 4 and 8mg is efficacious and tolerable, according to a study ...

ORLANDO -- More than 80% of patients with moderate or severe atopic dermatitis (AD) had at least 75% improvement after 12 ...

Absci Corp (ABSI) showcases promising advancements in drug creation and secures additional funding, despite modest revenue growth and increased R&D expenses.

The rising prevalence of prediabetes among young adults signals early metabolic dysfunction, significantly increasing the ...